Scaling up and expanding Right Care in the Right Place - immunoglobulins
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 838002828
Grant search
Key facts
Disease
COVID-19Start & end year
20212021Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
Drs. RAAL van RasResearch Location
N/ALead Research Institution
Alcura apotheekResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Establishment of the care pathway for immunoglobulin treatment in the home environment by Alcura. Due to JZOJP, reinforced by COVID, chronic medication treatments are increasingly given at home instead of in the hospital. This offers more comfort and quality for the patient. In collaboration with hospitals, Alcura has years of experience in supplying and administering specialist medication at home. This was often low-complex medication, for which a nurse provided administration or instructions. Highly complex care pathways, such as immunoglobulins, require new services, including infusion care, including infusion pumps and guidance of patients from infusion to subcutaneous administration. By motivating and training patients to administer their own medication, we promote self-management and the patient becomes independent of nursing care, so that Alcura can help other patients who need it. In this way we combine efficiency with personalized care.